{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T18:20:48Z","timestamp":1775240448248,"version":"3.50.1"},"reference-count":25,"publisher":"Medknow","issue":"2","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,22]],"date-time":"2013-07-22T00:00:00Z","timestamp":1374451200000},"content-version":"vor","delay-in-days":112,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["saudiophthaljournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Saudi Journal of Ophthalmology"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.sjopt.2013.02.001","type":"journal-article","created":{"date-parts":[[2013,2,11]],"date-time":"2013-02-11T21:31:06Z","timestamp":1360618266000},"page":"107-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["The gene therapy revolution in ophthalmology"],"prefix":"10.4103","volume":"27","author":[{"given":"Fahad I.","family":"Al-Saikhan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2581","reference":[{"key":"10.1016\/j.sjopt.2013.02.001_b0005","unstructured":"Silva, Nuno Filipe. Gene therapy for Stargardt and other ABCA4-related diseases: lessons from the RPE65-LCA trial. School of Medicine, University of Coimbra. Web: <https:\/\/estudogeral.sib.uc.pt>; 2010 [02.08.12]."},{"key":"10.1016\/j.sjopt.2013.02.001_b0010","unstructured":"MacLaren, Robert. Gene therapy. Nuffield Laboratory of Ophthalmology. <http:\/\/www.eye.ox.ac.uk>; [21.07.12]."},{"key":"10.1016\/j.sjopt.2013.02.001_b0015","unstructured":"Institute, National Cancer. Gene therapy for cancer: questions and answers. <http:\/\/www.cancer.gov>; [25.07.12]."},{"key":"10.1016\/j.sjopt.2013.02.001_b0020","unstructured":"Mandal, Ananya. Retinitis pigmentosa genetics. News Medical. <http:\/\/www.news-medical.net>; [21.07.12]."},{"key":"10.1016\/j.sjopt.2013.02.001_b0025","series-title":"Fraunfelder\u2019s current ocular therapy","author":"Frederick","year":"2007"},{"key":"10.1016\/j.sjopt.2013.02.001_b0030","unstructured":"Retinitis pigmentosa news and research. News medical. <http:\/\/www.news-medical.net>; [12.07.12]."},{"key":"10.1016\/j.sjopt.2013.02.001_b0035","series-title":"Ophthalmology","author":"Duker","year":"2009"},{"key":"10.1016\/j.sjopt.2013.02.001_b0125","series-title":"Progress in gene therapy: basic and clinical frontiers","author":"Nagatsu","year":"2000"},{"key":"10.1016\/j.sjopt.2013.02.001_b0045","unstructured":"What is gene therapy? News medical. <http:\/\/www.news-medical.net>; [15.07.12]."},{"issue":"6","key":"10.1016\/j.sjopt.2013.02.001_b0050","first-page":"412","article-title":"Clinical features of autosomal dominant retinitis pigmentosa associated","volume":"35","author":"Chen","year":"2006","journal-title":"Ann Acad Med"},{"key":"10.1016\/j.sjopt.2013.02.001_b0055","unstructured":"Hays, Dustin C. Canine study puts gene therapy for X-linked retinitis pigmentosa in sight. National Eye Institute. <http:\/\/www.nei.nih.gov>; [28.06.12]."},{"key":"10.1016\/j.sjopt.2013.02.001_b0060","unstructured":"Ghosh, Pallab. Gene therapy first for poor sight. Stargardt\u2019s Australia. <http:\/\/www.stargardts-au.org>; [26.06.12]."},{"issue":"2","key":"10.1016\/j.sjopt.2013.02.001_b0065","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/ilar.50.2.206","article-title":"AAV-mediated gene therapy for retinal disorders in large animal models","volume":"50","author":"Rolling","year":"2009","journal-title":"ILAR J."},{"issue":"3","key":"10.1016\/j.sjopt.2013.02.001_b0145","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/mt.2009.277","article-title":"Gene therapy for Leber\u2019s Congenital Amaurosis is safe and effective through 1.5 years after vector administration","volume":"18","author":"Simonelli","year":"2010","journal-title":"Mol Ther"},{"key":"10.1016\/j.sjopt.2013.02.001_b0130","unstructured":"Acton, Ashton Q. Leber congenital amaurosis: new insights for the healthcare professional. 2011 ed. Scholarly Paper. Atlanta: Scholarly Editions; 2011."},{"issue":"7","key":"10.1016\/j.sjopt.2013.02.001_b0075","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/gt.2011.3","article-title":"AAV-mediated photoreceptor transduction of the pig cone-enriched retina","volume":"18","author":"Mussolino","year":"2011","journal-title":"Gene Ther"},{"issue":"2","key":"10.1016\/j.sjopt.2013.02.001_b0080","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/13816810802626399","article-title":"RPE65: role in the visual cycle, human retinal disease, and gene therapy","volume":"30","author":"Cai","year":"2009","journal-title":"Ophthalmic Genet"},{"key":"10.1016\/j.sjopt.2013.02.001_b0085","series-title":"DNA and biotechnology","author":"Reichsman","year":"2009"},{"key":"10.1016\/j.sjopt.2013.02.001_b0090","unstructured":"Hammer, Robert. Stargardt disease. MD support. <http:\/\/www.mdsupport.org>; [28.07.12]."},{"key":"10.1016\/j.sjopt.2013.02.001_b0095","doi-asserted-by":"crossref","unstructured":"Nonviral DNA nanoparticles for ocular gene therapy to treat Stargardt\u2019s disease. SciBX 5(34); doi:10.1038\/scibx.2012.911. Aug. 30 2012.","DOI":"10.1038\/scibx.2012.911"},{"key":"10.1016\/j.sjopt.2013.02.001_b0100","unstructured":"Naash, Muna. Nanoparticle-based gene therapy preserves vision in lab study for Stargardt disease. Foundation Fighting Blindness. Web: <http:\/\/www.blindness.org>; [22.07.12]."},{"issue":"2","key":"10.1016\/j.sjopt.2013.02.001_b0105","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2147\/IJN.S1608","article-title":"Magnetic nanoparticles for gene and drug delivery","volume":"3","author":"Dobson","year":"2008","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.sjopt.2013.02.001_b0135","article-title":"Northwest science and technology. Gene therapy treats red-green colorblindness in adult monkeys","author":"Berezow","year":"2010","journal-title":"Spring"},{"key":"10.1016\/j.sjopt.2013.02.001_b0115","unstructured":"Gullagher S. Tufts. Gene therapy shows promise against age-related macular degeneration. April 29, 2011. Web: <http:\/\/now.tufts.edu>; [11.05.12]."},{"issue":"46","key":"10.1016\/j.sjopt.2013.02.001_b0140","first-page":"4","article-title":"RNA interference as a gene silencing therapy for mutant MYOC protein in primary open angle glaucoma","volume":"4","author":"Li","year":"2009","journal-title":"Diagn Pathol"}],"container-title":["Saudi Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319453413000258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319453413000258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T14:48:06Z","timestamp":1597934886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1319453413000258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S1319453413000258"],"URL":"https:\/\/doi.org\/10.1016\/j.sjopt.2013.02.001","relation":{},"ISSN":["1319-4534"],"issn-type":[{"value":"1319-4534","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The gene therapy revolution in ophthalmology","name":"articletitle","label":"Article Title"},{"value":"Saudi Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sjopt.2013.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}